In summary, we found that GalCer-driven changes in the expression of Bcl-2, TNFRSF1B, and TNFRSF9 were responsible for the sensitivity/resistance of BC cells to DOX-induced apoptosis. The gene discussed is TNFRSF9; the disease is breast cancer.